Quantcast
Channel: Investor Relations Marketing | Financial Public Relations
Browsing all 59 articles
Browse latest View live

Payment Data Systems (NASDAQ:PYDS) Well Positioned In Mobile Payments Industry

According to a report on the mobile payments industry, Business Insider notes that mobile transactions accounted for around 2% of all credit and debit card volume in the U.S. in 2013. Globally, mobile...

View Article



Actinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3...

NEW YORK, NY–(Marketwired – December 17, 2015) – Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), is a biopharmaceutical company developing innovative targeted payload...

View Article

Payment Data Systems Rings Closing Bell

The post Payment Data Systems Rings Closing Bell appeared first on .

View Article

Payment Data Systems (NASDAQ: PYDS): A Significantly Undervalued Company In...

The growth of e-commerce has boosted the outlook for the payments processing industry. Within the payment processing industry, mobile payments is one of the fastest growing areas. This does not come as...

View Article

Actinium Pharmaceuticals: A Small Cap Stock To Watch In The Biotech Space

The biotechnology sector has seen a multi-year rally that came to a halt only in mid-2015. However, the correction did not last long as the sector has seen a recovery in the last three months. The...

View Article


Payment Data Systems Announces Record Transaction Processing Results for the...

Introduces New eCheck Verification Service That Helps Merchants Prevent Returns Before Processing, Which Improves Quality of the ACH Network by Reducing Return Transactions SAN ANTONIO, Jan. 19, 2016...

View Article

Payment Data Systems (PYDS): Why This Mobile Payments Company Should Be On...

The mobile payments industry has been seeing significant growth, driven mainly by the increasing use of smartphones and tablets. Indeed, the industry has even piqued the interest of electronics payment...

View Article

Actinium (ATNM) Receives Orphan Drug Designation From FDA for Iomab-B in...

Orphan Drug Designation Anticipated to Provide Faster Regulatory Review, Financial Incentives and Market Exclusivity The post Actinium (ATNM) Receives Orphan Drug Designation From FDA for Iomab-B in...

View Article


Why Actinium Pharma (ATNM) Offers Favorable Risk/Reward Profile

2016 has so far turned out to be a challenging year for the biotechnology sector. The sector saw two sell-offs in 2015 but managed to finish the year on a strong note. However, the start of this year...

View Article


Payment Data Systems (PYDS) Offers Significant Upside

The phenomenal growth experienced by the mobile payments industry over the last few years has generated significant interest in the industry. The industry has seen consolidation since 2014. The growth...

View Article

Payment Data Systems (PYDS) Announces Growth in Credit Card Transactions for...

Payment Data Systems, Inc. (PYDS), an integrated electronic payments solutions provider, announced today its transactions processing volumes for the first quarter of 2016.  Credit card transaction...

View Article

Payment Data Systems (PYDS) Launches Kind Hand Solutions Platform for...

Payment Data Systems, Inc.(PYDS) today announced its launch of Kind Hand, a giving and registration management solution for churches and charitable organizations built on Spark Development Network’s...

View Article

Actinium Pharmaceuticals (ATNM) Remains Significantly Undervalued

The biotech sector has seen a sharp correction since late April. Since April 25th, the iShares NASDAQ Biotechnology Index (ETF) (IBB) has dropped more than 12%. If the sell-off continues over the next...

View Article


The Mobile Payments Industry Is Seeing Consolidation, Could PYDS Be Next?

Payment Data Systems Inc. (NASDAQ: PYDS) is a San Antonio, Texas processor of electronic payments for other companies. PYDS generates revenue across the payment processing value chain. The company has...

View Article

Actinium Pharmaceuticals (ATNM) Has Huge Potential

Celator Pharmaceuticals Inc. (NASDAQ: CPXX) has been one of the biggest gainers in the biotech sector this year. Year-to-date, CPXX has gained more than 1600%. Some of the gains have come recently...

View Article


Payment Data Systems: A High Risk/High Reward Opportunity In The Mobile...

The investment case for Payment Data Systems Inc. (NASDAQ: PYDS) is pretty straightforward. The mobile payments industry has been seeing phenomenal growth, driven by increasing use of smartphones and...

View Article

Actinium Pharmaceuticals (ATNM) Further Strengthens IP Portfolio: Memorial...

Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or the “Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced...

View Article


Actinium Pharmaceuticals (ATNM) Another Promising Name In The AML Space

While this has been a mixed year for the biotechnology sector, there have been some clear winners. Celator Pharmaceuticals Inc. (NASDAQ: CPXX) is one such winner. In fact, CPXX is one of the most...

View Article

Payment Data Systems (PYDS) A Small Cap FinTech Growth Opportunity

The payment processing industry is becoming increasingly complex with the onslaught of new entrants and technologies.  The main players in this segment offers services such as processing of...

View Article

Payment Data Systems Targeting Growth in 2017

Digital payment processing is an emerging, growing market, with China and the US leading the market in terms of volume.  It is growing at a tremendous rate compared to other forms of payments and money...

View Article
Browsing all 59 articles
Browse latest View live




Latest Images